Zhejiang Orient Gene Biotech Co Ltd (688298) — Capital Reinvestment Ratio
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Capital Reinvestment Ratio of 0.39x as of September 2022, meaning it reinvests 0% of its operating cash flow (CN¥309.89 Million) in capital expenditures (CN¥119.58 Million). Check 688298 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Orient Gene Biotech Co Ltd Capital Reinvestment Ratio (2016–2022)
This chart tracks Zhejiang Orient Gene Biotech Co Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see 688298 operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Year-by-year Capital Reinvestment Ratio for Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2022. See cash generation quality of Zhejiang Orient Gene Biotech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.35x | CN¥3.00 Billion | CN¥1.05 Billion | ▲ +259.8% |
| 2021 | 0.10x | CN¥5.20 Billion | CN¥507.87 Million | ▲ +37.7% |
| 2020 | 0.07x | CN¥1.79 Billion | CN¥126.93 Million | ▼ -67.7% |
| 2019 | 0.22x | CN¥54.21 Million | CN¥11.90 Million | ▼ -48.5% |
| 2018 | 0.43x | CN¥44.33 Million | CN¥18.88 Million | ▲ +6.7% |
| 2017 | 0.40x | CN¥33.54 Million | CN¥13.38 Million | ▲ +1.3% |
| 2016 | 0.39x | CN¥11.81 Million | CN¥4.65 Million | — |